RICHARD E RAMSAY
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Epilepsy MOBILE, AL NPI 1790740694
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Epilepsy AL UCB, Inc. All categories
General Payments — all program years on this page
$336,122.93
- Category: General Payments
- Program years: PY2018–2024
- Record count: 596
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $23,050.95 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,836.00 | 3 |
| Honoraria | $7,700.00 | 3 |
| Food and Beverage | $1,798.07 | 52 |
| Travel and Lodging | $716.88 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $10,903.39 | 17 |
| SK Life Science, Inc. | $8,173.74 | 14 |
| Neurelis, Inc. | $3,221.75 | 3 |
| JAZZ PHARMACEUTICALS INC. | $181.79 | 3 |
| ARGENX US, INC. | $111.81 | 4 |
| ACADIA Pharmaceuticals Inc | $89.82 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $52.02 | 2 |
| Grifols USA, LLC | $43.70 | 2 |
| Pyros Pharmaceuticals, Inc. | $32.51 | 2 |
| Amgen Inc. | $32.14 | 2 |
| ANI Pharmaceuticals, Inc. | $31.11 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $25.14 | 1 |
| Genentech USA, Inc. | $23.69 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.75 | 1 |
| Cadwell Industries, INC | $22.74 | 1 |
| Merz Pharmaceuticals, LLC | $22.54 | 1 |
| Vanda Pharmaceuticals Inc. | $21.76 | 1 |
| Neurocrine BioSciences, Inc. | $21.69 | 1 |
| ABBVIE INC. | $16.86 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.